Research Article
Optimization on Preparation Conditions of Salidroside Liposome and Its Immunological Activity on PCV-2 in Mice
Table 4
The results of EE of salidroside liposome PCV-2.
| | Liposome | The volume ratio | EE | TCID50 in liposome/0.2 mL | Total TCID50/0.2 mL |
| | Salidroside liposome I PCV-2 | 2 : 1 | 10% | 2.1 × 105 | 2.1 × 106 | | 3 : 1 | 30% | 4.7 × 105 | 1.6 × 106 | | 4 : 1 | 40% | 5.1 × 105 | 1.3 × 106 | | 5 : 1 | 60% | 6.3 × 105 | 1.1 × 106 | | 6 : 1 | 55% | 5.0 × 105 | 9.0 × 105 |
| | Salidroside liposome II PCV-2 | 2 : 1 | 8% | 3.3 × 105 | 4.2 × 106 | | 3 : 1 | 22% | 6.9 × 105 | 3.2 × 106 | | 4 : 1 | 44% | 7.0 × 105 | 1.6 × 106 | | 5 : 1 | 80% | 8.4 × 105 | 1.1 × 106 | | 6 : 1 | 76% | 6.9 × 105 | 9.0 × 105 |
| | Salidroside liposome III PCV-2 | 2 : 1 | 10% | 4.2 × 105 | 4.2 × 106 | | 3 : 1 | 30% | 9.5 × 105 | 3.2 × 106 | | 4 : 1 | 50% | 7.9 × 105 | 1.6 × 106 | | 5 : 1 | 75% | 7.9 × 105 | 1.1 × 106 | | 6 : 1 | 70% | 6.3 × 105 | 9.0 × 105 |
|
|
